Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
17.93
+2.08 (13.12%)
Apr 13, 2026, 4:00 PM EDT - Market closed
Burning Rock Biotech Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 478.39 | 519.85 | 615.1 | 905.45 | 1,431 |
Short-Term Investments | - | 6.14 | 13.41 | 2.09 | 65.63 |
Cash & Short-Term Investments | 478.39 | 525.99 | 628.5 | 907.55 | 1,497 |
Cash Growth | -9.05% | -16.31% | -30.75% | -39.37% | -33.84% |
Accounts Receivable | 181.91 | 165.87 | 149.61 | 151.71 | 134.59 |
Other Receivables | - | 0.18 | 1.18 | 0.1 | 0.11 |
Receivables | 181.91 | 166.05 | 150.79 | 151.81 | 138.2 |
Inventory | 56.98 | 62.63 | 69.02 | 130.32 | 123.21 |
Restricted Cash | 2.7 | 2.31 | 0.12 | 19.82 | 7.8 |
Other Current Assets | 18.61 | 19.65 | 35.67 | 49.27 | 54.79 |
Total Current Assets | 738.59 | 776.62 | 884.1 | 1,259 | 1,821 |
Property, Plant & Equipment | 73.87 | 100.34 | 144.2 | 300.03 | 406.45 |
Long-Term Investments | - | - | 0.34 | 0.69 | 0.91 |
Other Intangible Assets | 0.28 | 0.42 | 0.96 | 1.99 | 5.15 |
Other Long-Term Assets | 7.63 | 7.93 | 5.09 | 20.89 | 45.14 |
Total Assets | 820.38 | 885.31 | 1,040 | 1,587 | 2,279 |
Accounts Payable | 40.74 | 33.75 | 18.06 | 50.95 | 63.08 |
Accrued Expenses | 80.86 | 56.94 | 65.37 | 104.23 | 107.03 |
Short-Term Debt | - | - | - | - | 2.37 |
Current Portion of Long-Term Debt | 0.2 | - | - | - | - |
Current Portion of Leases | 16.76 | 24.57 | 8.63 | 37.24 | 35 |
Current Income Taxes Payable | - | 14.46 | 20.62 | 11.03 | 7.69 |
Current Unearned Revenue | 107.82 | 117.9 | 130.54 | 147.63 | 142.87 |
Other Current Liabilities | 0.59 | 18.69 | 20.14 | 60.38 | 14.14 |
Total Current Liabilities | 246.98 | 266.3 | 263.36 | 411.45 | 372.18 |
Long-Term Debt | 1.7 | - | - | - | - |
Long-Term Leases | 24.46 | 27.75 | 3.69 | 13.55 | 49.32 |
Other Long-Term Liabilities | 11.98 | 10.43 | 4.54 | 4.12 | 11.78 |
Total Liabilities | 285.11 | 304.48 | 271.59 | 429.13 | 433.28 |
Common Stock | 0.14 | 0.15 | 0.14 | 0.14 | 0.14 |
Additional Paid-In Capital | 5,010 | 5,002 | 4,849 | 4,583 | 4,281 |
Retained Earnings | -4,256 | -4,200 | -3,854 | -3,200 | -2,229 |
Treasury Stock | -57.19 | -63.26 | -65.9 | -58.92 | - |
Comprehensive Income & Other | -162.14 | -158.05 | -161.53 | -165.72 | -207.07 |
Total Common Equity | 535.26 | 580.83 | 768.41 | 1,158 | 1,845 |
Shareholders' Equity | 535.26 | 580.83 | 768.41 | 1,158 | 1,845 |
Total Liabilities & Equity | 820.38 | 885.31 | 1,040 | 1,587 | 2,279 |
Total Debt | 43.12 | 52.32 | 12.32 | 50.79 | 86.69 |
Net Cash (Debt) | 435.27 | 473.66 | 616.18 | 856.76 | 1,410 |
Net Cash Growth | -8.11% | -23.13% | -28.08% | -39.25% | -36.35% |
Net Cash Per Share | 40.36 | 46.02 | 60.18 | 82.45 | 135.33 |
Filing Date Shares Outstanding | 10.48 | 10.77 | 10.26 | 10.27 | 10.52 |
Total Common Shares Outstanding | 10.48 | 10.76 | 10.24 | 10.26 | 10.51 |
Working Capital | 491.61 | 510.32 | 620.73 | 847.31 | 1,449 |
Book Value Per Share | 51.09 | 53.97 | 75.01 | 112.85 | 175.56 |
Tangible Book Value | 534.98 | 580.41 | 767.45 | 1,156 | 1,840 |
Tangible Book Value Per Share | 51.06 | 53.93 | 74.92 | 112.66 | 175.07 |
Machinery | - | 307.49 | 348.07 | 339.09 | 297.89 |
Construction In Progress | - | 0.63 | 0.55 | 2.66 | 27.56 |
Leasehold Improvements | - | 187.23 | 187.39 | 187.38 | 161.04 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.